[en] Food allergy is a collective term for several immune-mediated responses to food. IgE-mediated food allergy is the best-known subtype. The patients present with a marked diversity of clinical profiles including symptomatic manifestations, threshold reactivity and reaction kinetics. In-vitro predictors of these clinical phenotypes are evasive and considered as knowledge gaps in food allergy diagnosis and risk management. Peanut allergy is a relevant disease model where pioneer discoveries were made in diagnosis, immunotherapy and prevention. This review provides an overview on the immune basis for phenotype variations in peanut-allergic individuals, in the light of future patient stratification along emerging omic-areas. Beyond specific IgE-signatures and basophil reactivity profiles with established correlation to clinical outcome, allergenomics, mass spectrometric resolution of peripheral allergen tracing, might be a fundamental approach to understand disease pathophysiology underlying biomarker discovery. Deep immune phenotyping is thought to reveal differential cell responses but also, gene expression and gene methylation profiles (eg, peanut severity genes) are promising areas for biomarker research. Finally, the study of microbiome-host interactions with a focus on the immune system modulation might hold the key to understand tissue-specific responses and symptoms. The immune mechanism underlying acute food-allergic events remains elusive until today. Deciphering this immunological response shall enable to identify novel biomarker for stratification of patients into reaction endotypes. The availability of powerful multi-omics technologies, together with integrated data analysis, network-based approaches and unbiased machine learning holds out the prospect of providing clinically useful biomarkers or biomarker signatures being predictive for reaction phenotypes.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
CZOLK, Rebecca Maria ; University of Luxembourg > Faculty of Science, Technology and Medicine (FSTM)
Klueber, Julia; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg ; Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis, University of Southern Denmark, Odense, Denmark
Sørensen, Martin; Department of Pediatric and Adolescent Medicine, University Hospital of North Norway, Tromsø, Norway ; Pediatric Research Group, Department of Clinical Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway
WILMES, Paul ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Systems Ecology
Codreanu-Morel, Françoise; Department of Allergology and Immunology, Centre Hospitalier de Luxembourg-Kanner Klinik, Luxembourg, Luxembourg
Skov, Per Stahl; Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis, University of Southern Denmark, Odense, Denmark ; RefLab ApS, Copenhagen, Denmark ; Institute of Immunology, National University of Copenhagen, Copenhagen, Denmark
Bindslev-Jensen, Carsten; Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis, University of Southern Denmark, Odense, Denmark
OLLERT, Markus ; University of Luxembourg ; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg ; Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis, University of Southern Denmark, Odense, Denmark
KUEHN, Annette ; University of Luxembourg ; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg
External co-authors :
yes
Language :
English
Title :
IgE-Mediated Peanut Allergy: Current and Novel Predictive Biomarkers for Clinical Phenotypes Using Multi-Omics Approaches.
FNR11823097 - Microbiomes In One Health, 2017 (01/09/2018-28/02/2025) - Paul Wilmes FNR11012546 - Next Generation Immunoscience: Advanced Concepts For Deciphering Acute And Chronic Inflammation, 2015 (01/01/2017-30/06/2023) - Markus Ollert
Funders :
Personalized Medicine Consortium
Funding number :
PMC/2017/02
Funding text :
Supported by the Luxembourg National Research Fund on PRIDE program grants PRIDE/11012546/NEXTIMMUNE and PRIDE17/11823097/MICROH; supported by the Personalized Medicine Consortium grant APSIS, PMC/2017/02 and by the Ministry of Research, Luxembourg.
Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy (2014) 69(8):1008–25. doi: 10.1111/all.12429
Sicherer SH, Sampson HA. Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J Allergy Clin Immunol (2018) 141(1):41–58. doi: 10.1016/j.jaci.2017.11.003
Anvari S, Miller J, Yeh CY, Davis CM. IgE-Mediated Food Allergy. Clin Rev Allergy Immunol (2019) 57(2):244–60. doi: 10.1007/s12016-018-8710-3
Gupta RS, Springston EE, Warrier MR, Smith B, Kumar R, Pongracic J, et al. The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics (2011) 128(1):e9–17. doi: 10.1542/peds.2011-0204
Gupta RS, Warren CM, Smith BM, Jiang J, Blumenstock JA, Davis MM, et al. Prevalence and Severity of Food Allergies Among US Adults. JAMA Netw Open (2019) 2(1):e185630. doi: 10.1001/jamanetworkopen.2018.5630
Fox M, Mugford M, Voordouw J, Cornelisse-Vermaat J, Antonides G, de la Hoz Caballer B, et al. Health sector costs of self-reported food allergy in Europe: a patient-based cost of illness study. Eur J Public Health (2013) 23(5):757–62. doi: 10.1093/eurpub/ckt010
Polloni L, Muraro A. Anxiety and food allergy: A review of the last two decades. Clin Exp Allergy (2020) 50(4):420–41. doi: 10.1111/cea.13548
Eiwegger T, Hung L, San Diego KE, O’Mahony L, Upton J. Recent developments and highlights in food allergy. Allergy (2019) 74(12):2355–67. doi: 10.1111/all.14082
Hammad H, Lambrecht BN. Barrier Epithelial Cells and the Control of Type 2 Immunity. Immunity (2015) 43(1):29–40. doi: 10.1016/j.immuni.2015.07.007
Chinthrajah RS, Hernandez JD, Boyd SD, Galli SJ, Nadeau KC. Molecular and cellular mechanisms of food allergy and food tolerance. J Allergy Clin Immunol (2016) 137(4):984–97. doi: 10.1016/j.jaci.2016.02.004
Sampath V, Tupa D, Graham MT, Chatila TA, Spergel JM, Nadeau KC. Deciphering the black box of food allergy mechanisms. Ann Allergy Asthma Immunol (2017) 118(1):21–7. doi: 10.1016/j.anai.2016.10.017
Valenta R, Hochwallner H, Linhart B, Pahr S. Food allergies: the basics. Gastroenterology (2015) 148(6):1120–31.e4. doi: 10.1053/j.gastro.2015.02.006
Tordesillas L, Berin MC, Sampson HA. Immunology of Food Allergy. Immunity (2017) 47(1):32–50. doi: 10.1016/j.immuni.2017.07.004
Sampson HA, O’Mahony L, Burks AW, Plaut M, Lack G, Akdis CA. Mechanisms of food allergy. J Allergy Clin Immunol (2018) 141(1):11–9. doi: 10.1016/j.jaci.2017.11.005
Chong KW, Ruiz-Garcia M, Patel N, Boyle RJ, Turner PJ. Reaction phenotypes in IgE-mediated food allergy and anaphylaxis. Ann Allergy Asthma Immunol (2020) 124(5):473–8. doi: 10.1016/j.anai.2019.12.023
Hourihane JO, Allen KJ, Shreffler WG, Dunngalvin G, Nordlee JA, Zurzolo GA, et al. Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy. J Allergy Clin Immunol (2017) 139(5):1583–90. doi: 10.1016/j.jaci.2017.01.030
Ruiz-Garcia M, Bartra J, Alvarez O, Lakhani A, Patel S, Tang A, et al. Cardiovascular changes during peanut-induced allergic reactions in human subjects. J Allergy Clin Immunol (2020). doi: 10.1016/j.jaci.2020.06.033
Ballmer-Weber BK, Fernandez-Rivas M, Beyer K, Defernez M, Sperrin M, Mackie AR, et al. How much is too much? Threshold dose distributions for 5 food allergens. J Allergy Clin Immunol (2015) 135(4):964–71. doi: 10.1016/j.jaci.2014.10.047
Glaumann S, Nopp A, Johansson SGO, Borres MP, Nilsson C. Oral Peanut Challenge Identifies an Allergy but the Peanut Allergen Threshold Sensitivity Is Not Reproducible. PloS One (2013) 8(1):e53465. doi: 10.1371/journal.pone.0053465
Poulsen LK, Jensen BM, Esteban V, Garvey LH. Beyond IgE-When Do IgE-Crosslinking and Effector Cell Activation Lead to Clinical Anaphylaxis? Front Immunol (2017) 8:871. doi: 10.3389/fimmu.2017.00871
Dua S, Ruiz-Garcia M, Bond S, Durham SR, Kimber I, Mills C, et al. Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: A randomized controlled study. J Allergy Clin Immunol (2019) 144(6):1584–94.e2. doi: 10.1016/j.jaci.2019.06.038
Savage J, Sicherer S, Wood R. The Natural History of Food Allergy. J Allergy Clin Immunol Pract (2016) 4(2):196–203. doi: 10.1016/j.jaip.2015.11.024
Verhoeckx KCM, van Broekhoven S, den Hartog-Jager CF, Gaspari M, de Jong GAH, Wichers HJ, et al. House dust mite (Der p 10) and crustacean allergic patients may react to food containing Yellow mealworm proteins. Food Chem Toxicol (2014) 65:364–73. doi: 10.1016/j.fct.2013.12.049
Ballardini N, Nopp A, Hamsten C, Vetander M, Melén E, Nilsson C, et al. Anaphylactic Reactions to Novel Foods: Case Report of a Child With Severe Crocodile Meat Allergy. Pediatrics (2017) 139(4):e20161404. doi: 10.1542/peds.2016-1404
Verhoeckx K, Lindholm Bøgh K, Constable A, Epstein MM, Hoffmann Sommergruber K, Holzhauser T, et al. COST Action ‘ImpARAS’: what have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium. Clin Transl Allergy (2020) 10:13. doi: 10.1186/s13601-020-00318-x
Akkerdaas J, Totis M, Barnett B, Bell E, Davis T, Edrington T, et al. Protease resistance of food proteins: a mixed picture for predicting allergenicity but a useful tool for assessing exposure. Clin Trans Allergy (2018) 8(1):30. doi: 10.1186/s13601-018-0216-9
Kalic T, Morel-Codreanu F, Radauer C, Ruethers T, Taki AC, Swoboda I, et al. Patients Allergic to Fish Tolerate Ray Based on the Low Allergenicity of Its Parvalbumin. J Allergy Clin Immunol Pract (2019) 7(2):500–8.e11. doi: 10.1016/j.jaip.2018.11.011
Klueber J, Costa J, Randow S, Codreanu-Morel F, Verhoeckx K, Bindslev-Jensen C, et al. Homologous tropomyosins from vertebrate and invertebrate: Recombinant calibrator proteins in functional biological assays for tropomyosin allergenicity assessment of novel animal foods. Clin Exp Allergy (2020) 50(1):105–16. doi: 10.1111/cea.13503
Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature (2009) 457(7229):585–8. doi: 10.1038/nature07548
Palladino C, Narzt MS, Bublin M, Schreiner M, Humeniuk P, Gschwandtner M, et al. Peanut lipids display potential adjuvanticity by triggering a pro-inflammatory response in human keratinocytes. Allergy (2018) 73(8):1746–9. doi: 10.1111/all.13475
Alessandri C, Ferrara R, Bernardi ML, Zennaro D, Tuppo L, Giangrieco I, et al. Molecular approach to a patient’s tailored diagnosis of the oral allergy syndrome. Clin Trans Allergy (2020) 10(1):22. doi: 10.1186/s13601-020-00329-8
Muraro A, Arasi S. Biomarkers in Food Allergy. Curr Allergy Asthma Rep (2018) 18(11):64. doi: 10.1007/s11882-018-0816-4
Sørensen M, Kuehn A, Mills ENC, Costello CA, Ollert M, Småbrekke L, et al. Cross-reactivity in fish allergy: A double-blind, placebo-controlled food-challenge trial. J Allergy Clin Immunol (2017) 140(4):1170–2. doi: 10.1016/j.jaci.2017.03.043
Datema MR, van Ree R, Asero R, Barreales L, Belohlavkova S, de Blay F, et al. Component-resolved diagnosis and beyond: Multivariable regression models to predict severity of hazelnut allergy. Allergy (2018) 73(3):549–59. doi: 10.1111/all.13328
Nilsson C, Berthold M, Mascialino B, Orme ME, Sjölander S, Hamilton RG. Accuracy of component-resolved diagnostics in peanut allergy: Systematic literature review and meta-analysis. Pediatr Allergy Immunol (2020) 31(3):303–14. doi: 10.1111/pai.13201
Flinterman AE, Knol EF, Lencer DA, Bardina L, den Hartog Jager CF, Lin J, et al. Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. J Allergy Clin Immunol (2008) 121(3):737–43.e10. doi: 10.1016/j.jaci.2007.11.039
Cerecedo I, Zamora J, Shreffler WG, Lin J, Bardina L, Dieguez MC, et al. Mapping of the IgE and IgG4 sequential epitopes of milk allergens with a peptide microarray-based immunoassay. J Allergy Clin Immunol (2008) 122(3):589–94. doi: 10.1016/j.jaci.2008.06.040
Nassiri M, Eckermann O, Babina M, Edenharter G, Worm M. Serum levels of 9α,11β-PGF2 and cysteinyl leukotrienes are useful biomarkers of anaphylaxis. J Allergy Clin Immunol (2016) 137(1):312–4.e7. doi: 10.1016/j.jaci.2015.07.001
Chan ES, Dinakar C, Gonzales-Reyes E, Green TD, Gupta R, Jones D, et al. Unmet needs of children with peanut allergy: Aligning the risks and the evidence. Ann Allergy Asthma Immunol (2020) 124(5):479–86. doi: 10.1016/j.anai.2020.01.016
Eller E, Bindslev-Jensen C. Clinical value of component-resolved diagnostics in peanut-allergic patients. Allergy (2013) 68(2):190–4. doi: 10.1111/all.12075
Hemmings O, Du Toit G, Radulovic S, Lack G, Santos AF. Ara h 2 is the dominant peanut allergen despite similarities with Ara h 6. J Allergy Clin Immunol (2020) 3:621–30. doi: 10.1016/j.jaci.2020.03.026
Cottel N, Saf S, Bourgoin-Heck M, Lambert N, Amat F, Poncet P, et al. Two Different Composite Markers Predict Severity and Threshold Dose in Peanut Allergy. J Allergy Clin Immunol Pract (2020) 1:275–82. doi: 10.1016/j.jaip.2020.09.043
Faber MA, Donné I, Herrebosch E, Sabato V, Hagendorens MM, Bridts CH, et al. Sensitization profiles to peanut allergens in Belgium; cracking the code in infants, children and adults. Acta Clin Belg (2016) 71(1):32–7. doi: 10.1080/17843286.2015.1109170
Giovannini M, Comberiati P, Piazza M, Chiesa E, Piacentini GL, Boner A, et al. Retrospective definition of reaction risk in Italian children with peanut, hazelnut and walnut allergy through component-resolved diagnosis. Allergol Immunopathol (Madr) (2019) 47(1):73–8. doi: 10.1016/j.aller.2018.03.009
Kaur N, Mehr S, Katelaris C, Wainstein B, Altavilla B, Saad R, et al. Added Diagnostic Value of Peanut Component Testing: A Cross-Sectional Study in Australian Children. J Allergy Clin Immunol Pract (2020) 1:245–53. doi: 10.1016/j.jaip.2020.08.060
Schwager C, Kull S, Behrends J, Röckendorf N, Schocker F, Frey A, et al. Peanut oleosins associated with severe peanut allergy-importance of lipophilic allergens for comprehensive allergy diagnostics. J Allergy Clin Immunol (2017) 140(5):1331–8.e8. doi: 10.1016/j.jaci.2017.02.020
Martinet J, Couderc L, Renosi F, Bobée V, Marguet C, Boyer O. Diagnostic Value of Antigen-Specific Immunoglobulin E Immunoassays against Ara h 2 and Ara h 8 Peanut Components in Child Food Allergy. Int Arch Allergy Immunol (2016) 169(4):216–22. doi: 10.1159/000446181
Mittag D, Akkerdaas J, Ballmer-Weber BK, Vogel L, Wensing M, Becker W-M, et al. Ara h 8, a Bet v 1–homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy. J Allergy Clin Immunol (2004) 114(6):1410–7. doi: 10.1016/j.jaci.2004.09.014
Asarnoj A, Nilsson C, Lidholm J, Glaumann S, Östblom E, Hedlin G, et al. Peanut component Ara h 8 sensitization and tolerance to peanut. J Allergy Clin Immunol (2012) 130(2):468–72. doi: 10.1016/j.jaci.2012.05.019
Song Y, Wang J, Leung N, Wang LX, Lisann L, Sicherer SH, et al. Correlations between basophil activation, allergen-specific IgE with outcome and severity of oral food challenges. Ann Allergy Asthma Immunol (2015) 114(4):319–26. doi: 10.1016/j.anai.2015.01.006
Lauer I, Dueringer N, Pokoj S, Rehm S, Zoccatelli G, Reese G, et al. The non-specific lipid transfer protein, Ara h 9, is an important allergen in peanut. Clin Exp Allergy (2009) 39(9):1427–37. doi: 10.1111/j.1365-2222.2009.03312.x
Romano A, Scala E, Rumi G, Gaeta F, Caruso C, Alonzi C, et al. Lipid transfer proteins: the most frequent sensitizer in Italian subjects with food-dependent exercise-induced anaphylaxis. Clin Exp Allergy (2012) 42(11):1643–53. doi: 10.1111/cea.12011
Garcia-Blanca A, Aranda A, Blanca-Lopez N, Perez D, Gomez F, Mayorga C, et al. Influence of age on IgE response in peanut-allergic children and adolescents from the Mediterranean area. Pediatr Allergy Immunol (2015) 26(6):497–502. doi: 10.1111/pai.12418
Shreffler WG, Beyer K, Chu T-HT, Burks AW, Sampson HA. Microarray immunoassay: Association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol (2004) 113(4):776–82. doi: 10.1016/j.jaci.2003.12.588
Lin J, Bruni FM, Fu Z, Maloney J, Bardina L, Boner AL, et al. A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay. J Allergy Clin Immunol (2012) 129(5):1321–8.e5. doi: 10.1016/j.jaci.2012.02.012
Bøgh KL, Nielsen H, Eiwegger T, Madsen CB, Mills ENC, Rigby NM, et al. IgE versus IgG4 epitopes of the peanut allergen Ara h 1 in patients with severe allergy. Mol Immunol (2014) 58(2):169–76. doi: 10.1016/j.molimm.2013.11.014
Dreskin SC, Germinaro M, Reinhold D, Chen X, Vickery BP, Kulis M, et al. IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy. Pediatr Allergy Immunol (2019) 30(8):817–23. doi: 10.1111/pai.13117
Mose AP, Mortz CG, Eller E, Sprogøe U, Barington T, Bindslev-Jensen C. Dose-time-response relationship in peanut allergy using a human model of passive cutaneous anaphylaxis. J Allergy Clin Immunol (2017) 139(6):2015–6.e4. doi: 10.1016/j.jaci.2016.11.034
Mose AP, Mortz E, Stahl Skov P, Mortz CG, Eller E, Sprogøe U, et al. The quest for ingested peanut protein in human serum. Allergy (2020) 75(7):1721–9. doi: 10.1111/all.14109
Bernard H, Turner PJ, Ah-Leung S, Ruiz-Garcia M, Clare Mills EN, Adel-Patient K. Circulating Ara h 6 as a marker of peanut protein absorption in tolerant and allergic humans following ingestion of peanut-containing foods. Clin Exp Allergy (2020) 50(9):1093–102. doi: 10.1111/cea.13706
JanssenDuijghuijsen LM, Wichers HJ, van Norren K, Keijer J, Baumert JL, de Jong GAH, et al. Detection of peanut allergen in human blood after consumption of peanuts is skewed by endogenous immunoglobulins. J Immunol Methods (2017) 440:52–7. doi: 10.1016/j.jim.2016.11.002
Moñino-Romero S, Lexmond WS, Singer J, Bannert C, Amoah AS, Yazdanbakhsh M, et al. Soluble FcεRI: A biomarker for IgE-mediated diseases. Allergy (2019) 74(7):1381–4. doi: 10.1111/all.13734
Santos AF, Du Toit G, O’Rourke C, Becares N, Couto-Francisco N, Radulovic S, et al. Biomarkers of severity and threshold of allergic reactions during oral peanut challenges. J Allergy Clin Immunol (2020) 2:344–55. doi: 10.1016/j.jaci.2020.03.035
Chinthrajah RS, Purington N, Andorf S, Rosa JS, Mukai K, Hamilton R, et al. Development of a tool predicting severity of allergic reaction during peanut challenge. Ann Allergy Asthma Immunol (2018) 121(1):69–76.e2. doi: 10.1016/j.anai.2018.04.020
Santos AF, Barbosa-Morais NL, Hurlburt BK, Ramaswamy S, Hemmings O, Kwok M, et al. IgE to epitopes of Ara h 2 enhance the diagnostic accuracy of Ara h 2-specific IgE. Allergy (2020) 75(9):2309–18. doi: 10.1111/all.14301
Crestani E, Harb H, Charbonnier L-M, Leirer J, Motsinger-Reif A, Rachid R, et al. Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthma. J Allergy Clin Immunol (2020) 145(3):897–906. doi: 10.1016/j.jaci.2019.10.014
Chiang D, Chen X, Jones SM, Wood RA, Sicherer SH, Burks AW, et al. Single-cell profiling of peanut-responsive T cells in patients with peanut allergy reveals heterogeneous effector T(H)2 subsets. J Allergy Clin Immunol (2018) 141(6):2107–20. doi: 10.1016/j.jaci.2017.11.060
Ruiter B, Smith NP, Monian B, Tu AA, Fleming E, Virkud YV, et al. Expansion of the CD4(+) effector T-cell repertoire characterizes peanut-allergic patients with heightened clinical sensitivity. J Allergy Clin Immunol (2020) 145(1):270–82. doi: 10.1016/j.jaci.2019.09.033
Tordesillas L, Rahman AH, Hartmann BM, Sampson HA, Berin MC. Mass cytometry profiling the response of basophils and the complete peripheral blood compartment to peanut. J Allergy Clin Immunol (2016) 138(6):1741–4.e9. doi: 10.1016/j.jaci.2016.06.048
Vadas P, Gold M, Perelman B, Liss GM, Lack G, Blyth T, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med (2008) 358(1):28–35. doi: 10.1056/NEJMoa070030
Arias K, Baig M, Colangelo M, Chu D, Walker T, Goncharova S, et al. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions. J Allergy Clin Immunol (2009) 124(2):307–14, 14.e1-2. doi: 10.1016/j.jaci.2009.03.012
Neeland MR, Andorf S, Manohar M, Dunham D, Lyu S-C, Dang TD, et al. Mass cytometry reveals cellular fingerprint associated with IgE+ peanut tolerance and allergy in early life. Nat Commun (2020) 11(1):1091. doi: 10.1038/s41467-020-14919-4
Rentzos G, Lundberg V, Lundqvist C, Rodrigues R, van Odijk J, Lundell AC, et al. Use of a basophil activation test as a complementary diagnostic tool in the diagnosis of severe peanut allergy in adults. Clin Transl Allergy (2015) 5:22. doi: 10.1186/s13601-015-0064-9
Santos AF, Douiri A, Bécares N, Wu SY, Stephens A, Radulovic S, et al. Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children. J Allergy Clin Immunol (2014) 134(3):645–52. doi: 10.1016/j.jaci.2014.04.039
Reier-Nilsen T, Michelsen MM, Lødrup Carlsen KC, Carlsen KH, Mowinckel P, Nygaard UC, et al. Predicting reactivity threshold in children with anaphylaxis to peanut. Clin Exp Allergy (2018) 48(4):415–23. doi: 10.1111/cea.13078
Santos AF, Du Toit G, Douiri A, Radulovic S, Stephens A, Turcanu V, et al. Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut. J Allergy Clin Immunol (2015) 135(1):179–86. doi: 10.1016/j.jaci.2014.09.001
Blom LH, Juel-Berg N, Larsen LF, Hansen KS, Poulsen LK. Circulating allergen-specific T(H)2 lymphocytes: CCR4(+) rather than CLA(+) is the predominant phenotype in peanut-allergic subjects. J Allergy Clin Immunol (2018) 141(4):1498–501.e5. doi: 10.1016/j.jaci.2017.10.037
DeLong JH, Simpson KH, Wambre E, James EA, Robinson D, Kwok WW. Ara h 1-reactive T cells in individuals with peanut allergy. J Allergy Clin Immunol (2011) 127(5):1211–8.e3. doi: 10.1016/j.jaci.2011.02.028
Renand A, Farrington M, Whalen E, Wambre E, Bajzik V, Chinthrajah S, et al. Heterogeneity of Ara h Component-Specific CD4 T Cell Responses in Peanut-Allergic Subjects. Front Immunol (2018) 9:1408. doi: 10.3389/fimmu.2018.01408
Weissler KA, Rasooly M, DiMaggio T, Bolan H, Cantave D, Martino D, et al. Identification and analysis of peanut-specific effector T and regulatory T cells in children allergic and tolerant to peanut. J Allergy Clin Immunol (2018) 141(5):1699–710.e7. doi: 10.1016/j.jaci.2018.01.035
Birrueta G, Tripple V, Pham J, Manohar M, James EA, Kwok WW, et al. Peanut-specific T cell responses in patients with different clinical reactivity. PloS One (2018) 13(10):e0204620. doi: 10.1371/journal.pone.0204620
Hong X, Hao K, Ladd-Acosta C, Hansen KD, Tsai HJ, Liu X, et al. Genome-wide association study identifies peanut allergy-specific loci and evidence of epigenetic mediation in US children. Nat Commun (2015) 6:6304. doi: 10.1038/ncomms7304
Martino DJ, Ashley S, Koplin J, Ellis J, Saffery R, Dharmage SC, et al. Genomewide association study of peanut allergy reproduces association with amino acid polymorphisms in HLA-DRB1. Clin Exp Allergy (2017) 47(2):217–23. doi: 10.1111/cea.12863
Asai Y, Eslami A, van Ginkel CD, Akhabir L, Wan M, Yin D, et al. A Canadian genome-wide association study and meta-analysis confirm HLA as a risk factor for peanut allergy independent of asthma. J Allergy Clin Immunol (2018) 141(4):1513–6. doi: 10.1016/j.jaci.2017.10.047
Asai Y, Eslami A, van Ginkel CD, Akhabir L, Wan M, Ellis G, et al. Genome-wide association study and meta-analysis in multiple populations identifies new loci for peanut allergy and establishes C11orf30/EMSY as a genetic risk factor for food allergy. J Allergy Clin Immunol (2018) 141(3):991–1001. doi: 10.1016/j.jaci.2017.09.015
Watson CT, Cohain AT, Griffin RS, Chun Y, Grishin A, Hacyznska H, et al. Integrative transcriptomic analysis reveals key drivers of acute peanut allergic reactions. Nat Commun (2017) 8(1):1943. doi: 10.1038/s41467-017-02188-7
Do AN, Watson CT, Cohain AT, Griffin RS, Grishin A, Wood RA, et al. Dual transcriptomic and epigenomic study of reaction severity in peanut-allergic children. J Allergy Clin Immunol (2020) 145(4):1219–30. doi: 10.1016/j.jaci.2019.10.040
Abdel-Gadir A, Stephen-Victor E, Gerber GK, Noval Rivas M, Wang S, Harb H, et al. Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy. Nat Med (2019) 25(7):1164–74. doi: 10.1038/s41591-019-0461-z
Hua X, Goedert JJ, Pu A, Yu G, Shi J. Allergy associations with the adult fecal microbiota: Analysis of the American Gut Project. EBioMedicine (2015) 3:172–9. doi: 10.1016/j.ebiom.2015.11.038
He Z, Vadali VG, Szabady RL, Zhang W, Norman JM, Roberts B, et al. Increased diversity of gut microbiota during active oral immunotherapy in peanut-allergic adults. Allergy (2020). doi: 10.1111/all.14540
Hoh RA, Joshi SA, Lee J-Y, Martin BA, Varma S, Kwok S, et al. Origins and clonal convergence of gastrointestinal IgE+ B cells in human peanut allergy. Sci Immunol (2020) 5(45):eaay4209. doi: 10.1126/sciimmunol.aay4209
Petersen A, Kull S, Rennert S, Becker WM, Krause S, Ernst M, et al. Peanut defensins: Novel allergens isolated from lipophilic peanut extract. J Allergy Clin Immunol (2015) 136(5):1295–301.e1-5. doi: 10.1016/j.jaci.2015.04.010
de Jong GAH, Jayasena S, Johnson P, Marsh J, Apostolovic D, van Hage M, et al. Purification and Characterization of Naturally Occurring Post-Translationally Cleaved Ara h 6, an Allergen That Contributes Substantially to the Allergenic Potency of Peanut. J Agric Food Chem (2018) 66(41):10855–63. doi: 10.1021/acs.jafc.8b03140
Mamone G, Di Stasio L, De Caro S, Picariello G, Nicolai MA, Ferranti P. Comprehensive analysis of the peanut allergome combining 2-DE gel-based and gel-free proteomics. Food Res Int (2019) 116:1059–65. doi: 10.1016/j.foodres.2018.09.045
Jappe U, Breiteneder H. Peanut allergy—Individual molecules as a key to precision medicine. Allergy (2019) 74(2):216–9. doi: 10.1111/all.13625
Beyer K, Grabenhenrich L, Härtl M, Beder A, Kalb B, Ziegert M, et al. Predictive values of component-specific IgE for the outcome of peanut and hazelnut food challenges in children. Allergy (2015) 70(1):90–8. doi: 10.1111/all.12530
Ebisawa M, Movérare R, Sato S, Borres M, Ito K. The predictive relationship between peanut- and Ara h 2–specific serum IgE concentrations and peanut allergy. J Allergy Clin Immunol In Pract (2015) 3:131–2.e1. doi: 10.1016/j.jaip.2014.10.014
van Veen LN, Heron M, Batstra M, van Haard PMM, de Groot H. The diagnostic value of component-resolved diagnostics in peanut allergy in children attending a Regional Paediatric Allergology Clinic. BMC Pediatr (2016) 16:74–. doi: 10.1186/s12887-016-0609-7
Stasio L, Picariello G, Mongiello M, Nocerino R, Berni Canani R, Bavaro SL, et al. Peanut digestome: Identification of digestion resistant IgE binding peptides. Food Chem Toxicol (2017) 107:88–98. doi: 10.1016/j.fct.2017.06.029
Prodic I, Stanic-Vucinic D, Apostolovic D, Mihailovic J, Radibratovic M, Radosavljevic J, et al. Influence of peanut matrix on stability of allergens in gastric-simulated digesta: 2S albumins are main contributors to the IgE reactivity of short digestion-resistant peptides. Clin Exp Allergy (2018) 48(6):731–40. doi: 10.1111/cea.13113
Dirks CG, Pedersen MH, Platzer MH, Bindslev-Jensen C, Skov PS, Poulsen LK. Does absorption across the buccal mucosa explain early onset of food-induced allergic systemic reactions? J Allergy Clin Immunol (2005) 115(6):1321–3. doi: 10.1016/j.jaci.2005.03.027
Schocker F, Baumert J, Kull S, Petersen A, Becker WM, Jappe U. Prospective investigation on the transfer of Ara h 2, the most potent peanut allergen, in human breast milk. Pediatr Allergy Immunol (2016) 27(4):348–55. doi: 10.1111/pai.12533
Pekar J, Ret D, Untersmayr E. Stability of allergens. Mol Immunol (2018) 100:14–20. doi: 10.1016/j.molimm.2018.03.017
Turcanu V, Maleki SJ, Lack G. Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J Clin Invest (2003) 111(7):1065–72. doi: 10.1172/jci16142
Noval Rivas M, Burton OT, Wise P, Charbonnier LM, Georgiev P, Oettgen HC, et al. Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy. Immunity (2015) 42(3):512–23. doi: 10.1016/j.immuni.2015.02.004
Wisniewski JA, Commins SP, Agrawal R, Hulse KE, Yu MD, Cronin J, et al. Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy. Clin Exp Allergy (2015) 45(7):1201–13. doi: 10.1111/cea.12537
Glanville J, Huang H, Nau A, Hatton O, Wagar LE, Rubelt F, et al. Identifying specificity groups in the T cell receptor repertoire. Nature (2017) 547(7661):94–8. doi: 10.1038/nature22976
Smith NP, Ruiter B, Virkud YV, Shreffler WG. Identification of antigen-specific TCR sequences using a strategy based on biological and statistical enrichment in unselected subjects. bioRxiv (2020) 2020.05.11.088286. doi: 10.1101/2020.05.11.088286
Brown SJ, Asai Y, Cordell HJ, Campbell LE, Zhao Y, Liao H, et al. Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol (2011) 127(3):661–7. doi: 10.1016/j.jaci.2011.01.031
Madore A-M, Vaillancourt VT, Asai Y, Alizadehfar R, Ben-Shoshan M, Michel DL, et al. HLA-DQB1*02 and DQB1*06:03P are associated with peanut allergy. Eur J Hum Genet (2013) 21(10):1181–4. doi: 10.1038/ejhg.2013.13
Marenholz I, Grosche S, Kalb B, Rüschendorf F, Blümchen K, Schlags R, et al. Genome-wide association study identifies the SERPINB gene cluster as a susceptibility locus for food allergy. Nat Commun (2017) 8(1):1056–. doi: 10.1038/s41467-017-01220-0
Heintz-Buschart A, Wilmes P. Human Gut Microbiome: Function Matters. Trends Microbiol (2018) 26(7):563–74. doi: 10.1016/j.tim.2017.11.002
Jiménez-Saiz R, Anipindi VC, Galipeau H, Ellenbogen Y, Chaudhary R, Koenig JF, et al. Microbial Regulation of Enteric Eosinophils and Its Impact on Tissue Remodeling and Th2 Immunity. Front Immunol (2020) 11:155(155). doi: 10.3389/fimmu.2020.00155
Petersen J, Ciacchi L, Tran MT, Loh KL, Kooy-Winkelaar Y, Croft NP, et al. T cell receptor cross-reactivity between gliadin and bacterial peptides in celiac disease. Nat Struct Mol Biol (2020) 27(1):49–61. doi: 10.1038/s41594-019-0353-4
Bresciani A, Paul S, Schommer N, Dillon MB, Bancroft T, Greenbaum J, et al. T-cell recognition is shaped by epitope sequence conservation in the host proteome and microbiome. Immunology (2016) 148(1):34–9. doi: 10.1111/imm.12585
Carrasco Pro S, Lindestam Arlehamn CS, Dhanda SK, Carpenter C, Lindvall M, Faruqi AA, et al. Microbiota epitope similarity either dampens or enhances the immunogenicity of disease-associated antigenic epitopes. PLoS One (2018) 13(5):e0196551. doi: 10.1371/journal.pone.0196551
Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature (2016) 535(7610):75–84. doi: 10.1038/nature18848
Wong KJ, Timbrell V, Xi Y, Upham JW, Collins AM, Davies JM. IgE+ B cells are scarce, but allergen-specific B cells with a memory phenotype circulate in patients with allergic rhinitis. Allergy (2015) 70(4):420–8. doi: 10.1111/all.12563
Saunders SP, Ma EGM, Aranda CJ, Curotto de Lafaille MA. Non-classical B Cell Memory of Allergic IgE Responses. Front Immunol (2019) 10:715(715). doi: 10.3389/fimmu.2019.00715
Kolmannskog S, Haneberg B. Immunoglobulin E in feces from children with allergy. Evidence of local production of IgE in the gut. Int Arch Allergy Appl Immunol (1985) 76(2):133–7. doi: 10.1159/000233679
Segal JP, Mullish BH, Quraishi MN, Acharjee A, Williams HRT, Iqbal T, et al. The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease. Therap Adv Gastroenterol (2019) 12:1756284818822250. doi: 10.1177/1756284818822250
Li L, Figeys D. Proteomics and Metaproteomics Add Functional, Taxonomic and Biomass Dimensions to Modeling the Ecosystem at the Mucosal-Luminal Interface. Mol Cell Proteomics (2020) 19(9):1409–17. doi: 10.1074/mcp.R120.002051
Arasi S, Mennini M, Valluzzi R, Riccardi C, Fiocchi A. Precision medicine in food allergy. Curr Opin Allergy Clin Immunol (2018) 18(5):438–43. doi: 10.1097/aci.0000000000000465
Delhalle S, Bode SFN, Balling R, Ollert M, He FQ. A roadmap towards personalized immunology. NPJ Syst Biol Appl (2018) 4(1):9. doi: 10.1038/s41540-017-0045-9
Donovan BM, Bastarache L, Turi KN, Zutter MM, Hartert TV. The current state of omics technologies in the clinical management of asthma and allergic diseases. Ann Allergy Asthma Immunol (2019) 123(6):550–7. doi: 10.1016/j.anai.2019.08.460
Dhondalay GK, Rael E, Acharya S, Zhang W, Sampath V, Galli SJ, et al. Food allergy and omics. J Allergy Clin Immunol (2018) 141(1):20–9. doi: 10.1016/j.jaci.2017.11.007
Krogulska A, Wood RA. Peanut allergy diagnosis: Moving from basic to more elegant testing. Pediatr Allergy Immunol (2020) 31(4):346–57. doi: 10.1111/pai.13215
Vickery BP, Vereda A, Casale TB, Beyer K, du Toit G, Hourihane JO, et al. AR101 Oral Immunotherapy for Peanut Allergy. N Engl J Med (2018) 379(21):1991–2001. doi: 10.1056/NEJMoa1812856
Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med (2015) 372(9):803–13. doi: 10.1056/NEJMoa1414850